Skip to main content

Novartis may still spin off Alcon, but not before 2019

Novartis AG has delayed a possible spin off of its eyecare division Alcon until the first half of 2019, amid signs of a turnaround in the ailing business.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.